Megan Smeykal - Feb 19, 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Accounting Officer, Controller
Signature
/s/ Megan Smeykal
Stock symbol
TELA
Transactions as of
Feb 19, 2025
Transactions value $
$0
Form type
4
Date filed
2/21/2025, 04:16 PM
Previous filing
Apr 2, 2024
Next filing
Feb 25, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +9.4K +31.25% $0.00 39.5K Feb 19, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,079 shares acquired under the Issuer's employee stock purchase plan on July 31, 2024.
F2 These restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.